03/05/2019 Transcatheter Heart Valves Greece 2019 | K. Papadopoulos | Lessons from the MITRA-FR and COAPT studies; How should we quantify MR?

info_icon

 

Δηλώνω υπεύθυνα ότι είμαι γιατρός ή εξασκώ παραϊατρικό επάγγελμα |

I hereby declare that I am a medical professional  

 

Συμφωνώ | Άκυρο

374 VIEWS EXPANDCOLLAPSE

Share

35,828 total
707 live
374 video
12,486 photo
Views:

3/5Αίθουσα Banquet Hall, MAICC -
18:30-20:00 JOINT SESSION II
Πρόεδροι: G. Athanassopoulos,G. Giamouzis,A. Trikas
18:30-18:45 Exercise-stress echocardiography and effort intolerance in asymptomatic/symptomatic degenerative mitral regurgitation
D. Klettas
18:45-19:00 Mitraclip vs. PASCAL. Similarities and differences
K. Spargias
19:00-19:15 Lessons from the MITRA-FR and COAPT studies; How should we quantify MR?
K. Papadopoulos
19:15-19:30 Percutaneous mitral repair after failed open surgery
S. Kar
19:30-19:45 Who are the best candidates for experimental TMVR in 2019?
N. Kleiman
19:45-20:00 Lessons from an International Registry on Transcatheter Tricuspid Thearapies
F. Maisano


 
Sort by Date | Views

Το 8o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών θα μεταδοθεί ζωντανά στο Livemedia
3 - 4 Μαίου 2019. Το Συνέδριο διοργανώνεται από το Διαγνωστικό Θεραπευτήριο Κέντρο Αθηνών Υγεία και θα πραγματοποιηθεί στο Μέγαρο Μουσικής Αθηνών.

Για περισσότερες πληροφορίες πατήστε εδώ.

G. Pattakos | Latest TAVR Randomized Trials... 294
M. Vavuranakis | High-Quality TAVR: Does... 262
S. Prapas | The selection of SAVR devices... 276
P. Dedeilas | Rapid Deployment Surgical... 283
WELCOME NOTES 262
A. Chalapas | CT Imaging of Bicuspid Aortic... 279
N. Van Mieghem | TAVR will be the treatment... 328
D. Angouras | Most Bicuspid aortic valves... 268
S. Kodali | Strokes After TAVR and SAVR:... 246
R. Mehran | What’s Holding Back Cerebral... 236
M. Οto | TAVR in the patient with significant... 223
A. Halapas | Live in a Box | TAVR Session... 275
L. Papavasileiou | Incidence, predictors... 279
N. Kleiman | Is paravalvular regurgitation... 243
S. Kapadia | A Selective versus Routine... 223
M. Οto | Management of Coronary Disease... 233
M. Chirssoheris | Live in a Box | TAVI Session... 232
A. Katsaros | Impact of valvular heart disease... 256
A. Patrianakos | Patient-prosthesis mismatch... 251
E. Anagnostou | Moderate aortic stenosis... 414
G. Pattakos | Minimally invasive surgery... 258
S. Kodali | In hospital mortality after... 214
G. Giamouzis - G. Karatasakis | JOINT SESSON... 256
S. Kapadia | TAVR for All? New insights... 225
J. Kisslo | Defining Secondary Mitral Regurgitation:... 239
S. Kar | Mitraclip for Functional Mitral... 224
D. Klettas | Exercise-stress echocardiography... 428
K. Spargias | Mitraclip vs. PASCAL. Similarities... 293
K. Papadopoulos | Lessons from the MITRA-FR... 374
S. Kar | Percutaneous mitral repair after... 229
N. Kleiman | Who are the best candidates... 244
F. Maisano | Lessons from an International... 277
M. Chrissoheris | Echocardiographic evaluation... 253
A. Pitsis | Mitral Valve-in-valve and valve-in-ring... 221
J. Velianou | Results of valve-in-MAC (mitral... 236
S. Kar | Currently enrolling TMVR and TTVR... 249
F. Maisano | You can’t beat safety and simplicity:... 234
N. Baikoussis - K. Bellos - E. Petropoulou... 225
K. Papadopoulos | Live in a box Mitraclip... 234
V. Voudris | A growing conundrum: Coronary... 239
N. Van Mieghem | Mechanisms of coronary... 230
N. Bouboulis | Hybrid beating heart bypass... 223
A. Manginas | Guidelines and classification... 218
R. Mehran | TAVR plus/minus AFib and/or... 226
G. Dangas | The Spectrum of Leaflet Thrombosis... 224
Discussion | TAVI Session IV – Avoiding Pitfalls 238
G. Pattakos |Live in a Box | TAVI Session... 221
M. Kasel | To crack or not to crack? The... 230
K. Spargias | Supra-annular TAVR devices.... 233
J. Velianou | To split or not to split?... 240
M. Kasel | The rapid emergence of transcaval... 204
P. Dardas | TAVR in the decompensated patient... 150
K. Dimitriadis | Transcatheter Heart Valves... 150
Discussion | TAVR Session V – Dealing with... 144
A. Οto - Transcatheter Heart Valves Greece... 149
S. Kapadia | Transcatheter Heart Valves Greece... 154
Σ.Παττακός | Transcatheter Heart Valves Greece... 136
K. Spargias | How far should we push the... 183
M. Chrissoheris | Live-in-a-box TAVR | TAVR... 150
A. Holzamer | The ACCURATE Neo TAVR system.... 154
L. Michalis | The PORTICO TAVR system. Program... 146
V. Martzaklis | Medtronic Structural Heart... 155
M. Kasel | What to expect in the near future... 126
L. Michalis | A Deep Dive Into TAVR Cost-Effectiveness... 133
M. Kasel | TAVR device selection in the... 141
J. Kisslo | Three-Dimensional Echocardiography... 144
F. Maisano | Patient selection for transcatheter... 158
M. Chrissoheris | Advanced echocardiography... 141
K. Spargias | Technical tips and tricks... 164
V. Ninios | An often Challenging MitraClip... 130
A. Tzifa | Transcatheter valve-in-valve... 193
A. Pitsis | Minimally invasive surgery for... 141
S. Pattakos | The Structural Heart and Valve... 139
C. Arampatzis | My best and/or my worst... 144
J. Iakovou | My best and/or my worst Structural... 140
G. Katsimagklis | My best and/or my worst... 135
D. Nikas | My best and/or my worst Structural... 147
K. Perreas | My best and/or my worst Structural... 142
K. Spiliotopoulos | My best and/or my worst... 134
K. Triantafyllou | My best and/or my worst... 123
D. Tsikaderis | My best and/or my worst... 134
I. Zarifis | My best and/or my worst Structural... 136
Closing of the conference 135